The company has received Form 483 from the US Food and Drug Administration (USFDA) for the company’s Ankleshwar unit.
The company will respond to the FDA within 15 days.
The scrip opened higher at Rs. 1,620 as against its previous close of Rs. 1,612.85. It hit a high and a low of Rs. 1,634 and Rs. 1,534.95 respectively. So far, 2.01 lk shares have changed hands on BSE.
An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgement may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. FDA investigators are trained to ensure that each observation noted on the FDA Form 483 is clear, specific and significant. Observations are made when in the investigator’s judgement, conditions or practices observed would indicate that any food, drug, device or cosmetic has been adulterated or is being prepared, packed, or held under conditions whereby it may become adulterated or rendered injurious to health.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2000 on 08-Apr-2015 and a 52 week low of Rs. 919.5 on 22-Dec-2014. Last one week high and low of the scrip stood at Rs. 1654 and Rs. 1577 respectively.
The promoters holding in the company stood at 74.2 % while Institutions and Non-Institutions held 11.63 % and 14.04 % respectively.
The stock is currently trading above its 50 DMA
No comments:
Post a Comment